AnaptysBio (ANAB) stock climbs as its antibody therapy rosnilimab meets key goals in mid-stage rheumatoid arthritis trial, ...

CFO Tom Szlosek reported Q4 revenue of $7.2 billion, a 7% year-over-year increase, driven by 12% growth in new vehicle revenue. Adjusted SG&A as a percentage of gross profit improved by more than 100 ...

Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas. You can ...